1460884481-6e166712-b2f2-4ce0-bd7c-7bdbd5f7156f

What is claimed is:

1. A process for molding a product from a composition in an injection molding apparatus having a feed throat which feeds a shot of composition into a mold, said composition comprising;
a) an unsaturated prepolymer resin which comprises one or more of unsaturated polyester and vinyl ester resin;
b) an unsaturated material copolymerizable with said resin and including a terminal ethylene group;
c) an inorganic particulate conductive filler in an amount sufficient to provide a bulk conductivity of at least 40 Scm to the resulting product; and
d) an initiator to initiate said copolymerization; and
wherein the composition is ported directly into the feed throat by an auger which has a vertical component to its positioning relative to the plane of the injection molding apparatus, and said shot is fed into the mold by a phenolic screw within the feed throat.
2. A process as set forth in claim 1 wherein the amount of said conductive filler is at least 50 weight percent.
3. A process as set forth in claim 2 wherein the filler is a graphite filler and the amount of said conductive filler is at least 60 weight percent.
4. A process as set forth in claim 1 wherein the composition further comprises an effective amount of a rheological modifier to prevent phase separation between said resin and said conductive filler during molding, said rheological modifier being one or more compositions selected from the group consisting of Group II oxides and hydroxides, carbodiamides, aziridines, polyisocyanates, polytetrafluorethylene, perfluoropolyether, polyethylene and fumed silica.
5. A process as set forth in claim 4 wherein said composition is molded into a product which has an intricate pattern molded therein and has a thickness from about 0.050 to about 0.200 inches and a bulk conductivity of at least about 50 Scm.
6. A process as set forth in claim 5 wherein said product is an electrochemical cell flow field plate.
7. A process as set forth in claim 6 wherein said conductive filler comprises a crystalline graphite particle and, and said unsaturated prepolymer resin is one or more resins selected from the group consisting of epoxy vinyl resin, bisphenol fumarate resin, modified bisphenol fumarate polyester resin, unsaturated polyester resin, urethane modified vinyl ester resin, bisphenol-epoxy vinylester resin, elastomer-modified vinyl ester resin, epoxy novolac vinyl ester resin and unsaturated isocyanurate vinyl ester resin.
7. A process as set forth in claim 7 wherein said auger is at an angle of from about 30 to about 60 from the horizontal plane of the injection molding apparatus.
8. A process as set forth in claim 8 wherein the auger is at an angle of from about 40 to about 50 degrees from the horizontal plane of the injection molding apparatus.
9. A process as set for the in claim I wherein the auger is substantially vertical and is feed by a second auger which is substantially horizontal relative to the plane of the injection molding apparatus.
10. A process as set forth in claim 9 wherein the phenolic screw has a tip which is modified to a constant inner diameter and a constant flight depth.
11. A process as set forth in claim 10 wherein the auger has been modified to match and blend into the feed throat area to eliminate any dead spots.
12. A process for molding a product from composition in an injection molding apparatus having a feed throat which feeds a shot of composition into a mold, said composition comprising;
a) an unsaturated prepolymer resin which comprises one or more of unsaturated polyester and vinyl ester resin;
b) an unsaturated material copolymerizable with said resin and including a terminal ethylene group;
c) an inorganic particulate conductive filler in an amount of at least about 50 weight percent of the weight of the composition;
d) an initiator to initiate said copolymerization; and
e) an effective amount of a rheological modifier to prevent phase separation between said resin and said conductive filler during molding, said rheological modifier being one or more compositions selected from the group consisting of Group II oxides and hydroxides, carbodiamides, aziridines, polyisocyanates, polytetrafluorethylene, perfluoropolyether, polyethylene and fumed silica; and
wherein the composition is ported directly into the feed throat by an auger which has a vertical component to its positioning relative to the plane of the injection molding apparatus, and said shot is fed into the mold by a phenolic screw within the feed throat.
13. A process as set forth in claim 12 wherein the filler is a graphite filler and the amount of said conductive filler is at least 60 weight percent.
14. A process as set forth in claim 13 wherein said composition is molded into a product which has an intricate pattern molded therein and has a thickness from about 0.050 to about 0.200 inches and a bulk conductivity of at least about 50 Scm.
15. A process as set forth in claim 14 wherein said product is an electrochemical cell flow field plate.
16. A process as set forth in claim 15 wherein said conductive filler comprises a crystalline graphite particle and, and said unsaturated prepolymer resin is one or more resins selected from the group consisting of epoxy vinyl resin, bisphenol fumarate resin, modified bisphenol fumarate polyester resin, unsaturated polyester resin, urethane modified vinyl ester resin, bisphenol-epoxy vinyl ester resin, elastomer-modified vinyl ester resin, epoxy novolac vinyl ester resin and unsaturated isocyanurate vinyl ester resin.
17. A process as set forth in claim 12 wherein said auger is at an angle of from about 30 to about 60 from the horizontal plane of the injection molding apparatus.
18. A process as set forth in claim 17 wherein the auger is at an angle of from about 40 to about 50 degrees from the horizontal plane of the injection molding apparatus.
19. A process as set for the in claim 12 wherein the auger is substantially vertical and is feed by a second auger which is substantially horizontal relative to the plane of the injection molding apparatus.
20. A process as set forth in claim 12 wherein the phenolic screw has a tip which is modified to a constant inner diameter and a constant flight depth.
21. A process as set forth in claim 20 wherein the auger has been modified to match and blend into the feed throat area to eliminate any dead spots.
22. An injection molding apparatus for molding a product from composition having at least about 50 weight percent of an inorganic particulate filler comprising;
a hopper having an auger with a vertical component to its positioning relative to the horizontal plane of the injection molding apparatus; and
an injection molding machine with a feed throat which feeds the composition into a phenolic screw which conveys the composition into a mold cavity wherein said auger has been modified to match and blend into the feed throat to eliminate any dead spots and the phenolic screw has a tip with a constant inner diameter and a constant flight depth.
23. An injection molding apparatus as set forth in claim 22 wherein the auger is at an angle of from about 40 to about 50 degrees from the horizontal plane of the injection molding apparatus.
24. A process as set for the in claim 22 wherein the auger is substantially vertical and is feed by a second auger which is substantially horizontal relative to the plane of the injection molding apparatus.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1-15. (canceled)
16. A transdermal patch, comprising
a pharmaceutical composition, which comprises:
a stabilized botulinum toxin; and
an enhancing agent that facilitates transdermal administration of the botulinum toxin in a bioactive form to a subdermal target site of a human patient without being administered to the patient’s circulatory system; and

an adhesive disposed on one side of the transdermal patch to removably secure the patch to the patient’s skin.
17. The transdermal patch of claim 16, wherein the adhesive is disposed around a depot containing the pharmaceutical composition.
18. The transdermal patch of claim 16, further comprising a plurality of needles extending from one side of the patch that is applied to the skin, wherein the needles extend from the patch to project through the stratum comeum of the skin without rupturing a blood vessel.
19. The transdermal patch of claim 18, wherein the botulinum toxin is provided in a depot in the patch so that pressure applied to the patch causes botulinum toxin to be directed through the needles and under the stratum comeum.
20. The transdermal patch of claim 16, wherein the botulinum toxin is provided in a dry state in a plurality of wells, each of the wells covered by a membrane that is dissolvable with a fluid, and wherein the enhancing agent mixes with the botulinum toxin as the membrane over a well dissolves so that the absorption of the botulinum toxin is enhanced.
21. The transdermal patch of claim 16, wherein the botulinum toxin is botulinum toxin type A.
22-35. (canceled)